Document is current
Any future updates will be listed below
-
Authors
McCall, Patrick M. https://orcid.org/0000-0002-6623-4673
Kim, Kyoohyun https://orcid.org/0000-0003-1808-775X
Shevchenko, Anna https://orcid.org/0009-0008-6157-4442
Ruer-Gruß, Martine
Peychl, Jan https://orcid.org/0000-0001-9556-2740
Guck, Jochen https://orcid.org/0000-0002-1453-6119
Shevchenko, Andrej https://orcid.org/0000-0002-5079-1109
Hyman, Anthony A. https://orcid.org/0000-0003-0851-704X
Brugués, Jan https://orcid.org/0000-0002-6731-4130
-
Funding
Funding for this research was provided by:
Volkswagen Foundation (96827)
Deutsche Forschungsgemeinschaft (EXC-2068– 390729961)
- License Information
-
More Information
Article History
Received: 22 November 2022
Accepted: 24 July 2025
First Online: 3 September 2025
Competing interests
: A.A.H. is a founder of Dewpoint Therapeutics and a member of the board as well as a shareholder in Caraway Therapeutics. The other authors declare no competing interests.
